Massoud Toussi

590 total citations
25 papers, 282 citations indexed

About

Massoud Toussi is a scholar working on Public Health, Environmental and Occupational Health, Pediatrics, Perinatology and Child Health and Economics and Econometrics. According to data from OpenAlex, Massoud Toussi has authored 25 papers receiving a total of 282 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Public Health, Environmental and Occupational Health, 9 papers in Pediatrics, Perinatology and Child Health and 4 papers in Economics and Econometrics. Recurrent topics in Massoud Toussi's work include Pregnancy and Medication Impact (7 papers), Pharmacological Effects and Toxicity Studies (5 papers) and Health Systems, Economic Evaluations, Quality of Life (4 papers). Massoud Toussi is often cited by papers focused on Pregnancy and Medication Impact (7 papers), Pharmacological Effects and Toxicity Studies (5 papers) and Health Systems, Economic Evaluations, Quality of Life (4 papers). Massoud Toussi collaborates with scholars based in France, United Kingdom and Israel. Massoud Toussi's co-authors include Alain Venot, Philippe Le Toumelin, Jean-Baptiste Lamy, Sigal Kaplan, Hartmut Richter, Siew Hwa Ong, B. Ehlken, Matthew Hankins, Andreas Clemens and Éric Van Ganse and has published in prestigious journals such as Allergy, British Journal of Clinical Pharmacology and Drug Safety.

In The Last Decade

Massoud Toussi

24 papers receiving 272 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Massoud Toussi France	8	57	42	41	40	37	25	282
Mary E. Ritchey United States	13	34 0.6×	13 0.3×	53 1.3×	26 0.7×	41 1.1×	32	564
Aarthi Iyer United States	10	79 1.4×	9 0.2×	28 0.7×	20 0.5×	37 1.0×	15	411
Paul Nderitu United Kingdom	11	27 0.5×	16 0.4×	26 0.6×	90 2.3×	8 0.2×	20	405
Ralph Kwame Akyea United Kingdom	13	75 1.3×	20 0.5×	69 1.7×	31 0.8×	12 0.3×	49	508
Gaurav Sharma United States	9	18 0.3×	13 0.3×	18 0.4×	22 0.6×	10 0.3×	20	301
Moneeza K. Siddiqui United Kingdom	12	234 4.1×	24 0.6×	28 0.7×	77 1.9×	15 0.4×	35	580
Monika Houstoun United States	8	35 0.6×	18 0.4×	41 1.0×	14 0.3×	22 0.6×	10	800
Ryogo Umetsu Japan	13	22 0.4×	77 1.8×	23 0.6×	30 0.8×	55 1.5×	21	467
Elizabeth Kern United States	9	90 1.6×	5 0.1×	21 0.5×	45 1.1×	20 0.5×	11	450
Ines Potočnjak Croatia	11	60 1.1×	13 0.3×	11 0.3×	51 1.3×	38 1.0×	34	390

Countries citing papers authored by Massoud Toussi

Since Specialization

Citations

This map shows the geographic impact of Massoud Toussi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Massoud Toussi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Massoud Toussi more than expected).

Fields of papers citing papers by Massoud Toussi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Massoud Toussi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Massoud Toussi. The network helps show where Massoud Toussi may publish in the future.

Co-authorship network of co-authors of Massoud Toussi

This figure shows the co-authorship network connecting the top 25 collaborators of Massoud Toussi. A scholar is included among the top collaborators of Massoud Toussi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Massoud Toussi. Massoud Toussi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kaplan, Sigal, et al.. (2024). Effectiveness of the Additional Risk Minimisation Measures for Valproate Among Healthcare Professionals and Patients: A Cross‐Sectional Survey in Six European Countries. Pharmacoepidemiology and Drug Safety. 33(11). e70046–e70046.

Afshari, Reza, et al.. (2023). A drug utilization study of thiocolchicoside‐containing medicinal products for systemic use in France and Italy: A cross‐sectional electronic medical records database study. Pharmacoepidemiology and Drug Safety. 32(10). 1093–1102. 1 indexed citations

Lysen, Thom S., et al.. (2023). Impact of European Union label changes to avoid inadvertent use of medicinal products containing methotrexate for once‐weekly administration: A survey amongst prescribers, pharmacists and patients on awareness, knowledge, and behaviour. Pharmacoepidemiology and Drug Safety. 33(1). e5692–e5692. 1 indexed citations

Toussi, Massoud, et al.. (2022). A cross‐sectional survey to evaluate prescribers' knowledge and understanding of safety messages following Dengvaxia® product information update. Pharmacoepidemiology and Drug Safety. 31(7). 758–768. 1 indexed citations

Ehlken, B., et al.. (2021). Eficacia de las medidas de minimización de riesgos del ácido valproico: estudio de utilización del fármaco en Europa, análisis de datos de España. Revista de Neurología. 73(11). 373–373. 2 indexed citations

Toussi, Massoud, et al.. (2020). Effectiveness of risk minimisation measures for valproate: A cross‐sectional survey among physicians in Europe. Pharmacoepidemiology and Drug Safety. 30(3). 283–291. 4 indexed citations

Ehlken, B., et al.. (2019). A drug utilization study to evaluate effectiveness of risk minimization measures for trimetazidine in France, Hungary, Romania and Spain. Journal of Clinical Pharmacy and Therapeutics. 44(3). 400–408. 1 indexed citations

Ehlken, B., et al.. (2018). Evaluation of the Reported Rates of Severe Hypersensitivity Reactions Associated with Ferric Carboxymaltose and Iron (III) Isomaltoside 1000 in Europe Based on Data from EudraVigilance and VigiBase™ between 2014 and 2017. Drug Safety. 42(3). 463–471. 23 indexed citations

Toussi, Massoud, et al.. (2018). Evaluation of the effectiveness of risk minimization measures for trimetazidine: A cross sectional joint PASS survey among physicians in selected European countries. Pharmacoepidemiology and Drug Safety. 27(12). 1385–1392. 7 indexed citations

10.

Belhassen, Manon, Pascal Demoly, Gérard de Pouvourville, et al.. (2017). Les coûts de la rhinite et de l’asthme augmentent avec le niveau de sévérité et de contrôle. Revue des Maladies Respiratoires. 34. A25–A26. 1 indexed citations

11.

Toussi, Massoud, Isabelle Bardoulat, Hasan S. Jafri, Judith Falloon, & Kellie Ryan. (2017). Healthcare Resource Utilization and Cost Related to Nosocomial Pneumonia Caused by Staphylococcus aureus and Pseudomonas aeruginosa in France: A 2010-2011 Population-Based Cohort Study Using a National Claims Database. Epidemiology Open Access. 7(4). 2 indexed citations

12.

Hankins, Matthew, et al.. (2016). Microvascular Outcomes in Patients with Type 2 Diabetes Treated with Vildagliptin vs. Sulfonylurea: A Retrospective Study Using German Electronic Medical Records. Diabetes Therapy. 7(3). 483–496. 28 indexed citations

13.

Belhassen, Manon, Pascal Demoly, Gérard de Pouvourville, et al.. (2016). Costs of perennial allergic rhinitis and allergic asthma increase with severity and poor disease control. Allergy. 72(6). 948–958. 36 indexed citations

14.

Toussi, Massoud, et al.. (2015). Using social media as the patient's voice in the benefit-risk assessment of drugs: Are we ready?. Medical Writing. 24(2). 77–81. 2 indexed citations

15.

Hughes, B., et al.. (2013). Understanding Patterns of Monitoring of Appropriate Prescribing in Europe. Value in Health. 16(7). A461–A461. 1 indexed citations

16.

Grandfils, N., B. Detournay, C. Attali, et al.. (2013). Glucose Lowering Therapeutic Strategies for Type 2 Diabetic Patients with Chronic Kidney Disease in Primary Care Setting in France: A Cross-Sectional Study. International Journal of Endocrinology. 2013. 1–6. 16 indexed citations

17.

Toussi, Massoud, Jean-Baptiste Lamy, Philippe Le Toumelin, & Alain Venot. (2009). Using data mining techniques to explore physicians' therapeutic decisions when clinical guidelines do not provide recommendations: methods and example for type 2 diabetes. BMC Medical Informatics and Decision Making. 9(1). 28–28. 48 indexed citations

18.

Toussi, Massoud, et al.. (2008). A novel method for measuring patients' adherence to insulin dosing guidelines: introducing indicators of adherence. BMC Medical Informatics and Decision Making. 8(1). 55–55. 11 indexed citations

19.

Toussi, Massoud, et al.. (2008). An automated method for analyzing adherence to therapeutic guidelines: application in diabetes.. PubMed. 136. 339–44. 6 indexed citations

20.

Toussi, Massoud, et al.. (2005). Representing the Patient's Therapeutic History in Medical Records and in Guideline Recommendations for Chronic Diseases Using a Unique Model.. PubMed. 116. 101–6. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact